Binding characteristics of tumor necrosis factor receptor-Fc fusion proteins vs anti-tumor necrosis factor mAbs

scientific article published in May 2007

Binding characteristics of tumor necrosis factor receptor-Fc fusion proteins vs anti-tumor necrosis factor mAbs is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ.JIDSYMP.5650034
P698PubMed publication ID17502862
P5875ResearchGate publication ID6329187

P2093author name stringJames S Louie
Seth R Stevens
Tadahiko Kohno
Lei-Ting T Tam
P2860cites workHuman anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trialQ28296771
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year periodQ34896269
Differentiating the efficacy of the tumor necrosis factor inhibitorsQ36106349
Clinical pharmacokinetics of TNF antagonists: how do they differ?Q36106353
The role of non-immune IgG in controlling IgG-mediated effector functionsQ40116339
Caspase activation and apoptosis induction by adalimumab: demonstration in vitro and in vivo in a chimeric mouse modelQ40336783
Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric modelQ40422633
Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functionsQ41355139
Granulomatous infectious diseases associated with tumor necrosis factor antagonistsQ47648712
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.Q53964227
Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor AntagonistsQ56864876
Granulomatous infections due to tumor necrosis factor blockade: correctionQ80867344
Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanerceptQ81361610
Reactivation of latent granulomatous infections by infliximabQ81898771
P433issue1
P304page(s)5-8
P577publication date2007-05-01
P1433published inThe journal of investigative dermatology. Symposium proceedingsQ26842290
P1476titleBinding characteristics of tumor necrosis factor receptor-Fc fusion proteins vs anti-tumor necrosis factor mAbs
P478volume12